E Marijuana Vs. Mushroom Psychedelic Drug Stocks

This article identifies the top 8 clinical-stage psychedelic drug companies in each of the marijuana and mushroom drug stock categories that comprise the constituents of munKNEE's Pure-Play Marijuana & Mushroom Psychedelic Drug Stocks Index. Here are the details:

One hundred clinical-stage psychedelic drug stocks now trade on North American stock exchanges. Sixty research the treatment of a variety of mental illnesses based on the use of "magic mushrooms" (psilocybin), ketamine, DMT, Ibogaine, LSD, or MDMA ("ecstasy"); 40 research the treatment of mental illnesses based on the use of THC marijuana.

Sixteen of the 100 clinical-stage psychedelic drug stocks - by chance evenly divided into each category - have market capitalizations in excess of $50M and less than $500M. and are included in the munKNEE Pure-Play Marijuana & Mushroom Psychedelic Drug Stocks Index. The remaining 84 stocks in the Index are nano-cap stocks (i.e. have market caps below $50M) and are not included in the Index.

Below is the stock price performance for each category last week, month to date and YTD and each major component price change with the reason(s) why, if any:

Marijuana-Based Category

The 8 marijuana-based research stocks in munKNEE's Pure-Play Marijuana & Mushroom Psychedelic Drug Stocks Index:

  • range in price from $0.03/share and $4.51/share (an average of $1.21/share)
  • with an average market capitalization of $104M.
  1. Zelira (ZLDAF): N/C, in the last 5 days, N/C since the beginning of July and +33.3% YTD.
  2. MGC (MGCLF): N/C, N/C and +50.0%, respectively.
  3. Allied Corp (ALID): -1.8%, +0.9% and 46.7%, respectively.
  4. Enveric (ENVB): -3.0%, -12.3% and -54.9%, respectively.
  5. Revive (RVVTF): -4.4%, -12.2% and -12.2% respectively.
  6. Corbus (CRBP): -4.7%, -21.2% and +12.8%, respectively.
  7. Tetro Bio (TBPMF): -8.7%, -22.2% and +40.0%, respectively.
  8. Zynerba (ZYNE): -13.1%, -13.8% and +36.7%, respectively.
    • All the above declines were due to general category weakness
1 2 3
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.